查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球超聲市場：按技術、組件、類型、應用、最終用戶、地區 - 預測（至 2028 年）
市場調查報告書
商品編碼
1330304

全球超聲市場：按技術、組件、類型、應用、最終用戶、地區 - 預測（至 2028 年）

Ultrasound Market by Technology, Component, Type, Application, End User & Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 259 Pages | 訂單完成後即時交付

價格
簡介目錄

全球超聲市場規模預計到 2023 年將達到 85 億美元，到 2028 年將達到 116 億美元，2023 年至 2028 年復合年增長率為 6.3%。Masu。

目標疾病的高患病率、診斷成像中心/程序數量的增加、人們對疾病早期診斷的好處的認識不斷增強、超聲功能和利用先進技術的模式的快速採用等。這些因素正在推動市場發展生長。

“診斷超聲的二維診斷超聲子系統細分市場將在 2022 年佔據最大市場份額。”

二維超聲提供的優勢，如實時成像、非侵入性操作、高分辨率、易於訪問和便攜，正在推動該產品領域的增長。

“預計在預測期內，便攜性細分市場的複合年增長率最高。”

2022 年，推車/推車超聲細分市場佔據最大市場份額。 該細分市場的大部分份額歸因於該系統的多功能性、圖像質量、先進功能、易用性以及在醫院和醫療機構的急症護理和緊急護理中的使用不斷增加。

“顯示器領域預計在預測期內復合年增長率最高。”

彩色超聲設備領域在2020年佔據了最大的市場份額。 這是由於彩色超聲設備提供的好處（更好的圖像質量、更高的圖像分辨率等）、先進彩色超聲設備的市場供應不斷擴大以及主要國家產品成本的持續下降，以及新興的這可能是由於國內主要製造商分銷網絡的擴張。

“預計北美市場在預測期內將呈現最高增長。”

這主要是由於該地區醫療保健支出高、目標疾病患病率上升、研究活動增加、整容手術增加以及成像系統技術進步。

本報告研究和分析了全球超聲市場，提供了關鍵驅動因素和限制因素、競爭格局和未來趨勢等信息。

目錄

第一章簡介

第二章研究方法

第 3 章執行摘要

第 4 章主要考慮因素

  • 超聲波市場概覽
  • 歐洲超聲市場：按技術分類
  • 亞太超聲市場：按最終用戶劃分
  • 超聲波市場：按顯示類型
  • 超聲市場的地理概況

第五章市場概述

  • 簡介
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 作業
  • 波特五力分析
  • 監管趨勢
  • 監管分析
  • 兌換場景
  • 生態系統映射
  • 價值鏈分析
  • 供應鏈分析
  • 專利分析
  • 貿易分析
  • 主要會議和活動
  • 技術分析
  • 案例研究分析
  • 價格分析

第 6 章超聲市場：按技術

  • 簡介
  • 超聲診斷
  • 治療性超聲

第 7 章超聲波市場：按顯示器分類

  • 簡介
  • 彩色超聲設備
  • 黑白超聲波設備

第 8 章超聲市場：便攜性

  • 簡介
  • 推車式超聲系統
  • 緊湊型/手持式超聲系統
  • POC超聲系統

第 9 章超聲市場：按應用劃分

  • 簡介
  • 放射學/一般成像應用
  • 心臟的用途
  • 婦產科應用
  • 泌尿外科應用
  • 血管的用途
  • 骨科和肌肉骨骼應用
  • 疼痛管理應用
  • 其他用途

第 10 章超聲市場：按組成部分

  • 簡介
  • 傳感器/探頭
  • 工作站
  • 其他組件

第 11 章超聲市場：按最終用戶劃分

  • 簡介
  • 醫院、手術中心、診斷中心
  • 婦產中心
  • 門診治療中心
  • 研究/學術
  • 其他最終用戶

第 12 章超聲市場：按地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 中東/非洲

第十三章競爭態勢

  • 摘要
  • 主要公司採取的策略
  • 收入份額分析
  • 市場份額分析
  • 主要企業評價矩陣（2022年）
  • 初創企業/中小企業評估矩陣（2022 年）
  • 競爭基準測試
  • 競爭場景和趨勢

第十四章公司簡介

  • 主要公司
    • GE HEALTHCARE
    • KONINKLIJKE PHILIPS N.V.
    • CANON MEDICAL SYSTEMS CORPORATION
    • SIEMENS AG
    • FUJIFILM CORPORATION
    • HOLOGIC, INC.
    • SAMSUNG ELECTRONICS CO., LTD.
    • MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • ESAOTE SPA
    • CHISON MEDICAL TECHNOLOGIES CO., LTD.
    • NEUSOFT CORPORATION
    • MOBISANTE, INC.
    • CLARIUS
    • MEDGYN PRODUCTS, INC.
    • PROMED TECHNOLOGY CO., LTD.
  • 其他公司
    • WHITE EAGLE SONIC TECHNOLOGIES, INC.
    • TELEMED ULTRASOUND
    • SHENZHEN RICSO TECHNOLOGY CO., LTD.
    • GUANGDONG YOUKEY MEDICAL CO., LTD.
    • ECHONOUS INC.
    • SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD.
    • SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENTS CO., LTD. (SIUI)
    • BUTTERFLY NETWORK, INC.
    • ALPINION MEDICAL SYSTEMS CO., LTD.
    • EDAN INSTRUMENTS, INC.

第15章附錄

簡介目錄
Product Code: MD 2885

The global ultrasound market is projected to reach USD 11.6 billion by 2028 from USD 8.5 billion in 2023, at a CAGR of 6.3% from 2023 to 2028. Factors such as the high incidence/prevalence of target diseases, the growing number of diagnostic imaging centers/procedures, increasing awareness about the benefits of early diagnosis of diseases, and the rapid adoption of technologically advanced ultrasound features and modalities are responsible for the increasing growth of this market.

"The 2D diagnostic ultrasound sub-systems segment of diagnostic ultrasound held the largest share of the market in 2022"

Based on technology, the ultrasound market is segmented into diagnostic ultrasound, therapeutic ultrasound, and contrast enhanced ultrasound. The diagnostic ultrasound segment of the market is further divided into 2D, 3D, 4D, doppler, and contrast enhanced ultrasound. The 2D subsegment held a major share of the market. Advantages offered by 2D ultrasound, such as real time imaging, non-invasive procedure, high-image resolution, and easy accessibility along with portability are driving the growth of this product segment.

"The portability segment is projected to register the highest CAGR during the forecast period"

Based on portability, the ultrasound market is segmented into trolley/cart-based ultrasound, compact/handheld ultrasound, and point-of-care (PoC) ultrasound. The trolley/cart-based ultrasound segment accounted for the largest market share in 2022. The large share of this segment is attributed to the system's versatility, image quality, ehanced, easy to use features, and due to the increased usage of it in acute care settings and emergency care in hospitals and healthcare institutions.

"The display segment is projected to register the highest CAGR during the forecast period"

On the basis of device display, the ultrasound market is segmented into black & white ultrasound and color ultrasound devices. The color ultrasound devices segment accounted for the largest share of the ultrasound market in 2020. This can be attributed to factors such as benefits offered by color ultrasound devices (including better image quality and higher image resolution), growing market availability of advanced color ultrasound devices (coupled with continuous decline in product cost across major countries), and expanding distribution networks of major manufacturers across emerging countries.

"The market in the North America region is expected to witness the highest growth during the forecast period."

The ultrasound market in the North America region is expected to register a CAGR during the forecast period, primarily due to the high healthcare spending in the region, rising prevalence of target diseases, increasing research activities, growing number of cosmetic surgeries, and technological advancements in imaging systems.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
  • By Designation: Director-level-14%, C-level-10%, and Others-76%
  • By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, and the Middle East & Africa-3%

The prominent players in the ultrasound market are GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Siemens AG (Germany), Hologic, Inc. (US), FUJIFILM Holdings Corporation (Japan), Samsung Electronics Co., Ltd. (Japan), and Mindray Medical International Limited (China), among others.

Research Coverage

This report studies the ultrasound market based on technology, display, portability, component, application, enduser, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall ultrasound market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

  • Analysis of key drivers (rising target patient population, growing adoption of multimodal PET imaging devices, technological advancement, and increasing investment, funds, and grants by public-private organizations), restraints (high capital and operational cost, unfavorable regulatory guidelines), opportunities (improving healthcare infrastructure across emerging countries, PET utilization for breast imaging, promising product pipeline), and challenges (availability of alternate imaging technologies) influencing the growth of the ultrasound market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the ultrasound market
  • Market Development: Comprehensive information about lucrative markets-the report analyses the ultrasound market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the ultrasound market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Siemens AG (Germany), Hologic, Inc. (US), FUJIFILM Corporation (Japan), Samsung Electronics Co., Ltd. (Japan), and Mindray Medical International Limited (China)

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 RESEARCH LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 ULTRASOUND MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primaries
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 5 MARKET SIZE ESTIMATION FOR ULTRASOUND MARKET: APPROACH 1 (COMPANY REVENUE ESTIMATION)
    • FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF GE HEALTHCARE
      • 2.2.1.2 Approach 2: Customer-based market estimation
      • 2.2.1.3 Ultrasound market: Top-down approach
      • 2.2.1.4 CAGR projection
    • FIGURE 7 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
  • 2.3 DATA VALIDATION APPROACH
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ASSESSMENT
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
    • 2.6.1 ULTRASOUND MARKET: RISK ASSESSMENT
  • 2.7 GROWTH RATE ASSUMPTIONS
  • 2.8 ULTRASOUND MARKET: RECESSION IMPACT

3 EXECUTIVE SUMMARY

    • FIGURE 9 ULTRASOUND MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 ULTRASOUND MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 ULTRASOUND MARKET, BY PORTABILITY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 ULTRASOUND MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF ULTRASOUND MARKET

4 PREMIUM INSIGHTS

  • 4.1 ULTRASOUND MARKET OVERVIEW
    • FIGURE 14 INCREASING INCIDENCE OF TARGET DISEASES AND SUBSEQUENT RISE IN SURGICAL PROCEDURES TO DRIVE MARKET
  • 4.2 EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY (USD MILLION)
    • FIGURE 15 DIAGNOSTIC ULTRASOUND SEGMENT TO HOLD LARGEST SHARE
  • 4.3 ASIA PACIFIC: ULTRASOUND MARKET, BY END USER
    • FIGURE 16 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.4 ULTRASOUND MARKET, BY DISPLAY TYPE
    • FIGURE 17 COLOR ULTRASOUND SEGMENT TO COMMAND LARGEST SHARE TILL 2028
  • 4.5 GEOGRAPHIC SNAPSHOT OF ULTRASOUND MARKET
    • FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of target diseases and subsequent rise in surgical procedures
      • 5.2.1.2 Growing patient preference for minimally invasive surgeries
      • 5.2.1.3 Rising technological advancements in ultrasound devices
      • 5.2.1.4 Growing public-private investments for product commercialization
      • 5.2.1.5 Increasing establishment of hospitals and diagnostic centers
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Unfavorable reimbursements
      • 5.2.2.2 High operating costs
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing applications of therapeutic ultrasound
      • 5.2.3.2 High growth potential of emerging markets
      • 5.2.3.3 Development of POC ultrasound systems
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Growing end-user preference for refurbished equipment
      • 5.2.4.2 Shortage of skilled sonographers
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 1 ULTRASOUND MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 REGULATORY TRENDS
  • 5.5 REGULATORY ANALYSIS
    • 5.5.1 NORTH AMERICA
      • 5.5.1.1 US
    • TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.5.1.2 Canada
    • TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.5.2 EUROPE
    • 5.5.3 ASIA PACIFIC
      • 5.5.3.1 Japan
    • TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.5.3.2 China
    • TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.5.3.3 India
  • 5.6 REIMBURSEMENT SCENARIO
    • TABLE 7 MEDICAL REIMBURSEMENT CPT CODES FOR ULTRASOUND PROCEDURES IN US (AS OF 2021)
  • 5.7 ECOSYSTEM MAPPING
  • 5.8 VALUE CHAIN ANALYSIS
    • 5.8.1 RESEARCH & PRODUCT DEVELOPMENT
    • 5.8.2 RAW MATERIAL AND MANUFACTURING
    • 5.8.3 MARKETING & SALES, SHIPMENT, AND POST-SALES SERVICES
    • FIGURE 20 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
  • 5.9 SUPPLY CHAIN ANALYSIS
    • 5.9.1 PROMINENT COMPANIES
    • 5.9.2 SMALL & MEDIUM-SIZED ENTERPRISES
    • 5.9.3 END USERS
    • TABLE 8 ULTRASOUND MARKET: SUPPLY CHAIN ECOSYSTEM
    • FIGURE 21 ULTRASOUND MARKET: SUPPLY CHAIN ANALYSIS
  • 5.10 PATENT ANALYSIS
    • FIGURE 22 PATENT DETAILS FOR ULTRASOUND (JANUARY 2013-JUNE 2023)
    • FIGURE 23 PATENTS FOR DIAGNOSTIC ULTRASOUND SYSTEMS (JANUARY 2013-JUNE 2023)
    • FIGURE 24 PATENTS FOR THERAPEUTIC ULTRASOUND SYSTEMS (JANUARY 2013-JUNE 2023)
  • 5.11 TRADE ANALYSIS
    • 5.11.1 ULTRASOUND MARKET: TRADE ANALYSIS
    • TABLE 9 IMPORT DATA FOR ULTRASOUND SYSTEMS (HS CODE 901812), BY COUNTRY, 2018-2022 (USD)
    • TABLE 10 EXPORT DATA FOR ULTRASOUND SYSTEMS (HS CODE 901812), BY COUNTRY, 2018-2022 (USD)
  • 5.12 KEY CONFERENCES AND EVENTS
    • TABLE 11 ULTRASOUND MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023-2025)
  • 5.13 TECHNOLOGY ANALYSIS
  • 5.14 CASE STUDY ANALYSIS
    • TABLE 12 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE
    • TABLE 13 CASE STUDY 2: PROVIDING COMPREHENSIVE TRAINING PROGRAMS FOR EVOLVING ULTRASOUND TECHNIQUES
  • 5.15 PRICING ANALYSIS
    • TABLE 14 REGIONAL PRICE RANGE FOR ULTRASOUND SYSTEMS

6 ULTRASOUND MARKET, BY TECHNOLOGY

  • 6.1 INTRODUCTION
    • TABLE 15 ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 6.2 DIAGNOSTIC ULTRASOUND
    • TABLE 16 DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 17 DIAGNOSTIC ULTRASOUND MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 18 DIAGNOSTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 2021-2028 (USD MILLION)
    • TABLE 19 DIAGNOSTIC ULTRASOUND MARKET, BY PORTABILITY, 2021-2028 (USD MILLION)
    • TABLE 20 DIAGNOSTIC ULTRASOUND MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 21 DIAGNOSTIC ULTRASOUND MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 6.2.1 2D ULTRASOUND
      • 6.2.1.1 Strong demand in emerging economies to drive market
    • TABLE 22 2D ULTRASOUND MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.2 3D & 4D ULTRASOUND
      • 6.2.2.1 Greater diagnostic accuracy and improved imaging capabilities to boost demand
    • TABLE 23 3D & 4D ULTRASOUND MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.3 DOPPLER ULTRASOUND
      • 6.2.3.1 Growing applications in pain management, cardiovascular imaging, and emergency care to drive market
    • TABLE 24 DOPPLER ULTRASOUND MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.4 CONTRAST-ENHANCED ULTRASOUND
      • 6.2.4.1 Availability of technologically advanced instruments to support growth
    • TABLE 25 CONTRAST-ENHANCED ULTRASOUND MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3 THERAPEUTIC ULTRASOUND
    • TABLE 26 THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 27 THERAPEUTIC ULTRASOUND MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 28 THERAPEUTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 2021-2028 (USD MILLION)
    • TABLE 29 THERAPEUTIC ULTRASOUND MARKET, BY PORTABILITY, 2021-2028 (USD MILLION)
    • TABLE 30 THERAPEUTIC ULTRASOUND MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 31 THERAPEUTIC ULTRASOUND MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 6.3.1 HIGH-INTENSITY FOCUSED ULTRASOUND
      • 6.3.1.1 Promising results associated with HIFU in cancer treatment to drive market
    • TABLE 32 HIGH-INTENSITY FOCUSED ULTRASOUND MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.2 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
      • 6.3.2.1 Growing emphasis on minimally invasive treatment of kidney & gallbladder stones to drive demand for ESWL
    • TABLE 33 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET, BY REGION, 2021-2028 (USD MILLION)

7 ULTRASOUND MARKET, BY DISPLAY

  • 7.1 INTRODUCTION
    • TABLE 34 ULTRASOUND MARKET, BY DISPLAY TYPE, 2021-2028 (USD MILLION)
  • 7.2 COLOR ULTRASOUND DEVICES
    • 7.2.1 RISING AVAILABILITY OF ADVANCED COLOR ULTRASOUND DEVICES TO DRIVE MARKET
    • TABLE 35 COLOR ULTRASOUND DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 BLACK & WHITE ULTRASOUND DEVICES
    • 7.3.1 ASIA PACIFIC REGION TO SHOW SUSTAINED DEMAND
    • TABLE 36 BLACK & WHITE ULTRASOUND DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)

8 ULTRASOUND MARKET, BY PORTABILITY

  • 8.1 INTRODUCTION
    • TABLE 37 ULTRASOUND MARKET, BY PORTABILITY, 2021-2028 (USD MILLION)
  • 8.2 TROLLEY/CART-BASED ULTRASOUND SYSTEMS
    • 8.2.1 RISING USAGE OF TROLLEY-BASED SYSTEMS IN ACUTE & EMERGENCY CARE TO DRIVE MARKET
    • TABLE 38 TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 COMPACT/HANDHELD ULTRASOUND SYSTEMS
    • 8.3.1 AFFORDABILITY AND PROCEDURAL & TECHNICAL BENEFITS TO DRIVE MARKET
    • TABLE 39 COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 8.4 POC ULTRASOUND SYSTEMS
    • 8.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST DEMAND
    • TABLE 40 POC ULTRASOUND SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)

9 ULTRASOUND MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 41 ULTRASOUND MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 9.2 RADIOLOGICAL/GENERAL IMAGING APPLICATIONS
    • 9.2.1 GROWING NUMBER OF IMAGE-GUIDED SURGERIES TO DRIVE MARKET
    • TABLE 42 ULTRASOUND MARKET FOR RADIOLOGICAL/GENERAL IMAGING APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • 9.3 CARDIOLOGICAL APPLICATIONS
    • 9.3.1 RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE MARKET
    • TABLE 43 ULTRASOUND MARKET FOR CARDIOLOGICAL APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • 9.4 OBSTETRIC/GYNECOLOGICAL APPLICATIONS
    • 9.4.1 WIDE USAGE IN OB/GYN APPLICATIONS TO BOOST GROWTH
    • TABLE 44 ULTRASOUND MARKET FOR OBSTETRIC/GYNECOLOGICAL APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • 9.5 UROLOGICAL APPLICATIONS
    • 9.5.1 GROWING PREVALENCE OF UROLOGICAL DISORDERS TO SUPPORT MARKET
    • TABLE 45 ULTRASOUND MARKET FOR UROLOGICAL APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • 9.6 VASCULAR APPLICATIONS
    • 9.6.1 VASCULAR APPLICATIONS TO WITNESS HIGH GROWTH
    • TABLE 46 ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • 9.7 ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS
    • 9.7.1 RISING PATIENT PREFERENCE FOR EARLY DIAGNOSIS TO DRIVE MARKET
    • TABLE 47 ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • 9.8 PAIN MANAGEMENT APPLICATIONS
    • 9.8.1 INCREASING USE IN TRAUMA & EMERGENCY CARE TO SUPPORT MARKET GROWTH
    • TABLE 48 ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • 9.9 OTHER APPLICATIONS
    • TABLE 49 ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)

10 ULTRASOUND MARKET, BY COMPONENT

  • 10.1 INTRODUCTION
    • TABLE 50 ULTRASOUND MARKET, BY COMPONENT, 2021-2028 (USD MILLION)
  • 10.2 TRANSDUCERS/PROBES
    • TABLE 51 ULTRASOUND TRANSDUCERS/PROBES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 52 ULTRASOUND TRANSDUCERS/PROBES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 10.2.1 CURVILINEAR/CONVEX ARRAYS
      • 10.2.1.1 Growing adoption of POC ultrasound to support growth
    • TABLE 53 CURVILINEAR/CONVEX ARRAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 10.2.2 LINEAR ARRAYS
      • 10.2.2.1 Rising target patient population to drive market
    • TABLE 54 LINEAR ARRAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 10.2.3 PHASED ARRAYS
      • 10.2.3.1 Technological advancements to drive market
    • TABLE 55 PHASED ARRAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 10.2.4 OTHER ARRAY TYPES
    • TABLE 56 OTHER ARRAY TYPES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.3 WORKSTATIONS
    • 10.3.1 GROWING DIAGNOSTIC PROCEDURAL VOLUMES TO FUEL DEMAND FOR WORKSTATIONS
    • TABLE 57 ULTRASOUND WORKSTATIONS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.4 OTHER COMPONENTS
    • TABLE 58 OTHER ULTRASOUND COMPONENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)

11 ULTRASOUND MARKET, BY END USER

  • 11.1 INTRODUCTION
    • TABLE 59 ULTRASOUND MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS
    • 11.2.1 HIGH PROCEDURAL VOLUMES TO ENSURE SUSTAINED DEMAND FOR ULTRASOUND
    • TABLE 60 ULTRASOUND MARKET FOR HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 11.3 MATERNITY CENTERS
    • 11.3.1 INCREASED ADOPTION OF ADVANCED ULTRASOUND FOR OB/GYN APPLICATIONS TO BOOST GROWTH
    • TABLE 61 ULTRASOUND MARKET FOR MATERNITY CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 11.4 AMBULATORY CARE CENTERS
    • 11.4.1 INCREASING EMPHASIS ON AMBULATORY CARE TO SUPPORT MARKET GROWTH
    • TABLE 62 ULTRASOUND MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 11.5 RESEARCH & ACADEMIA
    • 11.5.1 GROWING AVAILABILITY OF RESEARCH GRANTS & FUNDING TO DRIVE GROWTH
    • TABLE 63 ULTRASOUND MARKET FOR RESEARCH & ACADEMIA, BY REGION, 2021-2028 (USD MILLION)
  • 11.6 OTHER END USERS
    • TABLE 64 ULTRASOUND MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

12 ULTRASOUND MARKET, BY REGION

  • 12.1 INTRODUCTION
    • TABLE 65 ULTRASOUND MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 12.2 NORTH AMERICA
    • FIGURE 25 NORTH AMERICA: ULTRASOUND MARKET SNAPSHOT
    • TABLE 66 NORTH AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 NORTH AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 68 NORTH AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 69 NORTH AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 70 NORTH AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021-2028 (USD MILLION)
    • TABLE 71 NORTH AMERICA: ULTRASOUND MARKET, BY PORTABILITY, 2021-2028 (USD MILLION)
    • TABLE 72 NORTH AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 73 NORTH AMERICA: ULTRASOUND MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.2.1 US
      • 12.2.1.1 Advanced healthcare infrastructure and favorable regulations to drive market
    • TABLE 74 POCUS ULTRASOUND CPT CODES (2021)
    • TABLE 75 US: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 76 US: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 77 US: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 12.2.2 CANADA
      • 12.2.2.1 Growing awareness about early disease diagnosis to drive market
    • TABLE 78 CANADA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 79 CANADA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 80 CANADA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.3 EUROPE
    • TABLE 81 EUROPE: ULTRASOUND MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 82 EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 83 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 84 EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 85 EUROPE: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021-2028 (USD MILLION)
    • TABLE 86 EUROPE: ULTRASOUND MARKET, BY PORTABILITY, 2021-2028 (USD MILLION)
    • TABLE 87 EUROPE: ULTRASOUND MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 88 EUROPE: ULTRASOUND MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.1 GERMANY
      • 12.3.1.1 Increasing healthcare expenditure and government spending to drive market
    • TABLE 89 GERMANY: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 90 GERMANY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 91 GERMANY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 12.3.2 FRANCE
      • 12.3.2.1 Increasing target patient population and rising number of diagnostic tests for chronic diseases to drive market
    • TABLE 92 FRANCE: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 93 FRANCE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 FRANCE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 12.3.3 UK
      • 12.3.3.1 Growing government initiatives and increasing incidences of chronic diseases to drive market
    • TABLE 95 UK: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 96 UK: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 97 UK: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 12.3.4 ITALY
      • 12.3.4.1 Increased availability of reimbursement coverage for diagnostic procedures to drive market
    • TABLE 98 ITALY: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 99 ITALY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 100 ITALY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 12.3.5 SPAIN
      • 12.3.5.1 Increasing prevalence of cancer and growing private-public funding to drive market
    • TABLE 101 SPAIN: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 102 SPAIN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 103 SPAIN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 12.3.6 REST OF EUROPE
    • TABLE 104 REST OF EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 105 REST OF EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 REST OF EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.4 ASIA PACIFIC
    • FIGURE 26 ASIA PACIFIC: ULTRASOUND MARKET SNAPSHOT
    • TABLE 107 ASIA PACIFIC: ULTRASOUND MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 108 ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 109 ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 110 ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 111 ASIA PACIFIC: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021-2028 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: ULTRASOUND MARKET, BY PORTABILITY, 2021-2028 (USD MILLION)
    • TABLE 113 ASIA PACIFIC: ULTRASOUND MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: ULTRASOUND MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.1 CHINA
      • 12.4.1.1 Increasing healthcare reforms and rising government investments to drive market
    • TABLE 115 CHINA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 116 CHINA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 117 CHINA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 12.4.2 JAPAN
      • 12.4.2.1 Fast adoption of advanced technologies and growth in geriatric population to drive market
    • TABLE 118 JAPAN: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 119 JAPAN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 120 JAPAN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 12.4.3 INDIA
      • 12.4.3.1 Increasing number of diagnostic procedures and improving healthcare infrastructure to drive market
    • TABLE 121 INDIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 122 INDIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 123 INDIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 12.4.4 AUSTRALIA
      • 12.4.4.1 Growing healthcare spending and increasing investments in research to drive market
    • TABLE 124 AUSTRALIA: ULTRASOUND REIMBURSEMENT SCENARIO
    • TABLE 125 AUSTRALIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 126 AUSTRALIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 127 AUSTRALIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 12.4.5 SOUTH KOREA
      • 12.4.5.1 Well-developed healthcare system and rising awareness of diseases to drive market
    • TABLE 128 SOUTH KOREA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 129 SOUTH KOREA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 130 SOUTH KOREA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 12.4.6 REST OF ASIA PACIFIC
    • TABLE 131 REST OF ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 132 REST OF ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 133 REST OF ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.5 LATIN AMERICA
    • TABLE 134 LATIN AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 135 LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 136 LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 137 LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 138 LATIN AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021-2028 (USD MILLION)
    • TABLE 139 LATIN AMERICA: ULTRASOUND MARKET, BY PORTABILITY, 2021-2028 (USD MILLION)
    • TABLE 140 LATIN AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 141 LATIN AMERICA: ULTRASOUND MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.5.1 BRAZIL
      • 12.5.1.1 Greater purchasing power and favorable demographic conditions to drive market
    • TABLE 142 BRAZIL: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 143 BRAZIL: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 144 BRAZIL: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 12.5.2 MEXICO
      • 12.5.2.1 Increased medical tourism and better government healthcare initiatives to drive market
    • TABLE 145 MEXICO: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 146 MEXICO: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 147 MEXICO: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 12.5.3 REST OF LATIN AMERICA
    • TABLE 148 REST OF LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 149 REST OF LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 150 REST OF LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 GROWING MEDICAL TOURISM AND INCREASING QUALITY HEALTHCARE SYSTEMS TO DRIVE MARKET
    • TABLE 151 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 152 MIDDLE EAST & AFRICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 153 MIDDLE EAST & AFRICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 154 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021-2028 (USD MILLION)
    • TABLE 155 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY PORTABILITY, 2021-2028 (USD MILLION)
    • TABLE 156 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 157 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY END USER, 2021-2028 (USD MILLION)

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ULTRASOUND MARKET
  • 13.3 REVENUE SHARE ANALYSIS
    • FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN ULTRASOUND MARKET, 2022
  • 13.4 MARKET SHARE ANALYSIS
    • FIGURE 28 MARKET SHARE ANALYSIS OF TOP PLAYERS IN ULTRASOUND MARKET, 2022
    • TABLE 158 ULTRASOUND MARKET: DEGREE OF COMPETITION
  • 13.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • FIGURE 29 ULTRASOUND MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
  • 13.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 STARTING BLOCKS
    • 13.6.3 RESPONSIVE COMPANIES
    • 13.6.4 DYNAMIC COMPANIES
    • FIGURE 30 ULTRASOUND MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
  • 13.7 COMPETITIVE BENCHMARKING
    • TABLE 159 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS
    • TABLE 160 PRODUCT FOOTPRINT ANALYSIS
    • TABLE 161 REGIONAL FOOTPRINT ANALYSIS
  • 13.8 COMPETITIVE SCENARIO AND TRENDS
    • TABLE 162 PRODUCT LAUNCHES, JANUARY 2020-JUNE 2023
    • TABLE 163 DEALS, JANUARY 2020-JUNE 2023
    • TABLE 164 OTHER DEVELOPMENTS, JANUARY 2020-JUNE 2023

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
  • (Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)**
    • 14.1.1 GE HEALTHCARE
    • TABLE 165 GE HEALTHCARE: COMPANY OVERVIEW
    • FIGURE 31 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
    • 14.1.2 KONINKLIJKE PHILIPS N.V.
    • TABLE 166 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
    • FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
    • 14.1.3 CANON MEDICAL SYSTEMS CORPORATION
    • TABLE 167 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
    • FIGURE 33 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2022)
    • 14.1.4 SIEMENS AG
    • TABLE 168 SIEMENS AG: COMPANY OVERVIEW
    • FIGURE 34 SIEMENS AG: COMPANY SNAPSHOT (2022)
    • 14.1.5 FUJIFILM CORPORATION
    • TABLE 169 FUJIFILM CORPORATION: COMPANY OVERVIEW
    • FIGURE 35 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022)
    • 14.1.6 HOLOGIC, INC.
    • TABLE 170 HOLOGIC, INC.: COMPANY OVERVIEW
    • FIGURE 36 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
    • 14.1.7 SAMSUNG ELECTRONICS CO., LTD.
    • TABLE 171 SAMSUNG ELECTRONICS CO., LTD.: COMPANY OVERVIEW
    • FIGURE 37 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2021)
    • 14.1.8 MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • TABLE 172 MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
    • FIGURE 38 MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2021)
    • 14.1.9 ESAOTE SPA
    • TABLE 173 ESAOTE SPA: COMPANY OVERVIEW
    • 14.1.10 CHISON MEDICAL TECHNOLOGIES CO., LTD.
    • TABLE 174 CHISON MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
    • 14.1.11 NEUSOFT CORPORATION
    • TABLE 175 NEUSOFT CORPORATION: COMPANY OVERVIEW
    • FIGURE 39 NEUSOFT CORPORATION: COMPANY SNAPSHOT (2022)
    • 14.1.12 MOBISANTE, INC.
    • TABLE 176 MOBISANTE, INC.: COMPANY OVERVIEW
    • 14.1.13 CLARIUS
    • TABLE 177 CLARIUS: COMPANY OVERVIEW
    • 14.1.14 MEDGYN PRODUCTS, INC.
    • TABLE 178 MEDGYN PRODUCTS, INC.: COMPANY OVERVIEW
    • 14.1.15 PROMED TECHNOLOGY CO., LTD.
    • TABLE 179 PROMED TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • *Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
  • 14.2 OTHER COMPANIES
    • 14.2.1 WHITE EAGLE SONIC TECHNOLOGIES, INC.
    • 14.2.2 TELEMED ULTRASOUND
    • 14.2.3 SHENZHEN RICSO TECHNOLOGY CO., LTD.
    • 14.2.4 GUANGDONG YOUKEY MEDICAL CO., LTD.
    • 14.2.5 ECHONOUS INC.
    • 14.2.6 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD.
    • 14.2.7 SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENTS CO., LTD. (SIUI)
    • 14.2.8 BUTTERFLY NETWORK, INC.
    • 14.2.9 ALPINION MEDICAL SYSTEMS CO., LTD.
    • 14.2.10 EDAN INSTRUMENTS, INC.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS